4,4,5,5-tetramethyl-2-(2-(2-methylcyclopropyl)phenyl)-1,3,2-dioxaborolane

Catalog No. :
ACTMHJ627
CAS No. :
2621936-38-5
Molecular Formula :
C16H23BO2
Molecular Weight :
258.17

IUPAC Name:4,4,5,5-tetramethyl-2-(2-(2-methylcyclopropyl)phenyl)-1,3,2-dioxaborolane

4,4,5,5-tetramethyl-2-(2-(2-methylcyclopropyl)phenyl)-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4,5,5-tetramethyl-2-(2-(2-methylcyclopropyl)phenyl)-1,3,2-dioxaborolane
IUPAC Name4,4,5,5-tetramethyl-2-(2-(2-methylcyclopropyl)phenyl)-1,3,2-dioxaborolane
Molecular FormulaC16H23BO2
Molecular Weight258.17
SMILESCC1(C)OB(C2=C(C3CC3C)C=CC=C2)OC1(C)C
InChI KeyZECXCMQVLXRYPQ-UHFFFAOYSA-N
Synonym1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[2-(2-methylcyclopropyl)phenyl]-;4,4,5,5-Tetramethyl-2-(2-(2-methylcyclopropyl)phenyl)-1,3,2-dioxaborolane
CAS No.2621936-38-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTMHJ627 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMHJ627 route product structure diagram
    ACTMHJ6272621936-38-5
Inquiry

2. ACTMHJ627 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPIOG508 route compound structure diagram
    ACPIOG508269410-06-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMHJ627 route product structure diagram
    ACTMHJ6272621936-38-5
Inquiry

Comments (0)